Second clinical trial now completed

A second successful clinical trial carried out in New Zealand by Southern Clinical Trials Group Ltd, has been completed as scheduled at the end of 2015.  

The double blinded, placebo (emollient) controlled clinical trial with 62 eczema subjects has demonstrated that Atopis significantly reduces the symptoms of eczema including intensity, severity, itching and scaling.



Older Post Newer Post